Additionally, the expression of complement C1s in ESCC patients was examined through RT-PCR, immunohistochemistry, and high-throughput sequencing analysis, revealing the elevated C1s expression within ESCC tumor samples relative to adjacent non-cancerous tissues. Here, C1S is linked to neoplasm.